Market cap
₹65 Cr
Revenue (TTM)
₹49 Cr
P/E Ratio
3.7
P/B Ratio
2.9
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹18 Cr
-
ROE
-30.1 %
-
ROCE
-30.1 %
-
Industry P/E
33.99
-
EV/EBITDA
19.9
-
Debt to Equity
0
-
Book Value
₹32.9
-
EPS
₹3.1
-
Face value
10
-
Shares outstanding
6,826,960
10 Years Aggregate
CFO
₹2.04 Cr
EBITDA
₹-3.79 Cr
Net Profit
₹-2.51 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Phaarmasia
| -15.2 | 1.8 | 23.4 | 199.7 | 55.3 | 26.6 | 15.9 |
|
BSE Healthcare
| 18.8 | 2.8 | 8.7 | 17.1 | 23.1 | 14.8 | 12.4 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Phaarmasia
| 139.9 | 26.5 | 41.4 | -15.7 | -8.9 | 125.7 | 5.6 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Phaarmasia
|
95.6 | 65.3 | 48.6 | 17.7 | 3.4 | 12.9 | 3.7 | 2.9 |
| 7,106.5 | 17,765.6 | 2,432.1 | 169.6 | 8.7 | 20.8 | 104.7 | 19.6 | |
| 2,517.2 | 19,125.3 | 2,287.3 | 678.1 | 31.4 | 19.7 | 28.7 | 5.1 | |
| 2,079.5 | 12,740.0 | 1,479.1 | 198.6 | 18.6 | 30.3 | 64 | 15.8 | |
| 1,314.8 | 18,252.8 | 3,229.7 | 666.9 | 26.6 | 18.8 | 28.3 | 4.5 | |
| 4,703.8 | 21,500.8 | 2,569.8 | 735.2 | 34.4 | 19.2 | 29.2 | 4.9 | |
| 5,670.5 | 9,412.3 | 1,432.9 | 356.9 | 30.8 | 58.2 | 26.4 | 15.3 | |
| 3,181.6 | 7,325.6 | 1,805.2 | 323.8 | 24.7 | 43.7 | 22.6 | 8.9 | |
| 903.8 | 17,685.5 | 1,682.5 | 273.5 | 21.0 | 11.1 | 59.5 | 6.6 | |
| 1,019.9 | 9,406.7 | 5,004.4 | 635.3 | 14.5 | 19.8 | 15.3 | 2.9 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Phaarmasia
Phaarmasia Limited manufactures and sells pharmaceutical products in India and internationally. It offers cosmetics, toothpastes, and oral contraceptive pills. The company was incorporated in 1981 and is based in Hyderabad, India.
-
Incorporated
1981
-
Chairman
--
-
Managing Director
--
-
Headquarters
Hyderabad, Telangana
-
Website
FAQs for Phaarmasia
What is the current share price of Phaarmasia Ltd Today?
The share price of Phaarmasia Ltd is ₹95.59 (BSE) as of 28-Aug-2026 IST. Phaarmasia Ltd has given a return of 55.34% in the last 3 years.
What is the current PB & PE ratio of Phaarmasia Ltd?
The P/E ratio of Phaarmasia Ltd is 3.70 times as on 28-Aug-2026, a 89 discount to its peers’ median range of 33.99 times.
The P/B ratio of Phaarmasia Ltd is 2.91 times as on 28-Aug-2026, a 42 discount to its peers’ median range of 5.06 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
0.00 |
4.45 |
2024 |
0.00 |
3.28 |
2023 |
0.00 |
2.43 |
2022 |
0.00 |
2.70 |
2021 |
54.38 |
1.80 |
What is the 52 Week High and Low of Phaarmasia Ltd?
The 52-week high and low of Phaarmasia Ltd are Rs 131.75 and Rs 30.01 as of 29-Aug-2026.
What is the market cap of Phaarmasia Ltd?
Phaarmasia Ltd has a market capitalisation of ₹ 65 Cr as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Phaarmasia Ltd?
Before investing in Phaarmasia Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.